Physician profile
Ritchie R Plummer
NPI 1285638023
$1,415.26
in general payments reported to CMS, 2019-2025
19 companies · $74.33 in 2025
The $74.33 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $53.03 · 2021: $395 · 2022: $330 · 2023: $222 · 2024: $157 · 2025: $74.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $402.20 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $294.22 | 2022-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $248.65 | 2019-2024 | |
| Amarin Pharma, INC. | $70.98 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.61 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.62 | 2019-2024 | Jardiance |
| Eisai INC. | $33.08 | 2021-2022 | |
| Pfizer INC. | $31.07 | 2019-2021 | |
| Phadia US INC. | $28.84 | 2021 | |
| Abbvie INC. | $28.52 | 2023-2025 | |
| Esperion Therapeutics, INC. | $24.47 | 2021 | |
| Amgen INC. | $22.89 | 2024 | Otezla, Repatha |
| Sanofi-Aventis U.S. LLC | $21.34 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.51 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.83 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $13.66 | 2024 | Gemtesa |
| Lilly USA, LLC | $13.55 | 2023 | Mounjaro |
| Nestle Healthcare Nutrition INC. | $13.03 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ritchie Plummer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.